Abstract: Several tryptophan (Trp) residues are conserved in G protein-coupled receptors (GPCRs). Relatively little is known about the contribution of these residues and especially of those in the fourth transmembrane domain in the function of the CB 2 cannabinoid receptor. Replacing W158 (very highly conserved in GPCRs) and W172 (conserved in CB 1 and CB 2 cannabinoid receptors but not in many other GPCRs) of the human CB 2 receptor with A or L or with F or Y produced different results. We found that the conservative change of W172 to F or Y retained cannabinoid binding and downstream signaling (inhibition of adenylyl cyclase), whereas removal of the aromatic side chain by mutating W172 to A or L eliminated agonist binding. W158 was even more sensitive to being mutated. We found that the conservative W158F mutation retained wild-type binding and signaling activities. However, W158Y and W158A mutants completely lost ligand binding capacity. Thus, the Trp side chains at positions 158 and 172 seem to have a critical, but different, role in cannabinoid binding to the human CB 2 receptor.
Relatively little is known about the structure-function relationship of the CB 2 cannabinoid receptor and about which amino acids in the various transmembrane (TM) domains are involved in ligand binding. However, progress is currently being made using site-directed mutagenesis of the CB 1 and CB 2 receptors (Chin et al., 1998; Tao and Abood, 1998; Tao et al., 1999) . For example, it was reported that Lys 192 in TM3 of CB 1 is crucial for receptor recognition by the tricyclic and bicyclic cannabinoids HU-210 and CP55,940, respectively, as well as by the endogenous cannabinoid anandamide but not by the aminoalkylindole cannabinoid WIN55,212-2 (Song and Bonner, 1996; Chin et al., 1998) . Moreover, Chin et al. (1999) and Song et al. (1999) reported that Ser 112 (TM3) and Phe 197 (TM5) of CB 2 are crucial for the selectivity of WIN55,212-2 for this receptor. It was also shown that substitution of the highly conserved Asp residue in TM2 of CB 1 (Asp 163 ) and CB 2 (Asp 80 ) with Asn or Glu disrupts G protein coupling to both receptors (Tao and Abood, 1998) .
Several Trp residues in various receptors were shown to play a role in receptor-ligand recognition (Wess et al., 1993; Matsui et al., 1995; Befort et al., 1996; Sautel et al., 1996; Roth et al., 1997) . W158, located just below the middle of TM4 of the human CB 2 receptor (position 4.50 in the nomenclature of Ballesteros and Weinstein, 1995) (Fig. 1) is completely conserved in all currently known G protein-coupled receptors (GPCRs), suggesting that this residue may have an important role in receptor structure and function (Probst et al., 1992; Wess et al., 1993; Baldwin et al., 1997) . Indeed, this Trp residue was shown to have an important role in ligand binding to various receptors, including the ␦-opioid, 5-HT 2A serotonergic, m 1 and m 3 muscarinic, and human Y 1 receptors (Wess et al., 1993; Matsui et al., 1995; Befort et al., 1996; Sautel et al., 1996; Roth et al., 1997) . Much less is known about W172 (at position 4.64, at the top of TM4 of the CB 2 receptor). This Trp is conserved in the CB 1 and CB 2 cannabinoid receptors of all species investigated (human and mouse CB 2 ; human, mouse, cat, and rat CB 1 ), as well as in several other GPCRs (including the ␤-adrenergic and m 1 -m 5 muscarinic receptors), but is not conserved in most other known GPCRs (Probst et al., 1992; Baldwin et al., 1997; Horn et al., 1998) , suggesting that it may have a role in the binding of specific ligands, e.g., cannabinoids, to their receptors. For example, substitution of this residue in the m 1 muscarinic receptor (W164A) led to a reduction in the binding affinity of acetylcholine to the receptor (Matsui et al., 1995) .
To examine the role of these Trp residues in CB 2 cannabinoid receptor binding and signaling [inhibition of adenylyl cyclase (AC)], we have mutated them into F, Y, or A and, in the case of W172, also to L. The results of these studies imply that both W158 and W172 have an important role in the binding of cannabinoid ligands to the human CB 2 receptor. 
MATERIALS AND METHODS

Materials
Plasmids
Rabbit AC type V (AC-V) and ␤-galactosidase cDNAs in the pXMD1 vector (Wallach et al., 1994) were described previously (Avidor-Reiss et al., 1997; Rhee et al., 1998) . The human CB 2 cDNA in pCDM8 was kindly provided by Dr. S. Munro (Cambridge, U.K.).
Construction of hemagglutinin (HA)-tagged human CB 2 in pcDNA3
The following oligonucleotide primers (P1 and P2) were synthesized and used to amplify (by PCR) a 1,100-bp fragment containing the entire human CB 2 coding sequence (using the human CB 2 cDNA in pCDM8 as a template): P1, 5Ј-GCG-GATCCGAGGAATGCTGGGTG-3Ј sense primer; P2, 5Ј-GCGCGGCCGCTCAGCAATCAGAGAG-3Ј antisense primer. P1 is homologous to the cDNA sequence at the CB 2 coding start site and was engineered to contain a unique BamHI site (underlined) for in-frame subcloning into a BglII site at the carboxy end of the HA sequence in HA-pcDNA3 (Coso et al., 1995) . The P2 sequence was designed to introduce a unique NotI site (underlined) for ligation into the multiple cloning site of pcDNA3. The 1,100-bp PCR product (following 25 cycles of 1-min denaturation at 92°C, 1-min annealing at 45°C, and 1-min extension at 72°C) was digested with BamHI and NotI and cloned into the BglII and NotI sites of HA-pcDNA3. The DNA sequence was confirmed by sequencing at the Weizmann Institute's DNA Sequencing Unit.
Preparation of point mutations in HA-CB 2
Mutations were introduced using the PCR-overlap extension method as previously described (Ho et al., 1989) . In brief, two general primers were designed for PCR that cover the region in HA-CB 2 where the mutations were planned. The 5Ј general primer 5Ј-GCCCTCATACCTGTTCATTGGC-3Ј (complementing a coding sequence in CB 2 upstream of the area of the mutation) and the 3Ј general primer 5Ј-GAGCTCTAGCATT-TAGGTGACACTATAG-3Ј (complementing part of the SP6 sequence of pcDNA3) were used in conjunction with internal sense and matching antisense primers that contained the desired mutation. Three PCR procedures were done: the first two providing the 5Ј and 3Ј ends of the mutated fragment and the third consecutive reaction joining the separate fragments. The final PCR product was cut with BstEII and BglII (unique sites, present in HA-CB 2 , before and beyond the area of the mutation), the mutated fragments were cloned into HA-CB 2 , and the DNA sequences of the various HA-CB 2 mutants were confirmed.
Transient cell transfection
At 24 h before transfection, a confluent 10-cm-diameter plate of COS-7 cells in Dulbecco's modified Eagle's medium supplemented with 5% fetal calf serum, 100 U/ml penicillin, and 100 g/ml streptomycin in a humidified atmosphere consisting of 5% CO 2 and 95% air at 37°C was trypsinized and split into five 10-cm-diameter plates. The cells were transfected, using the DEAE-dextran chloroquine method (Keown et al., 1990) , with wild-type (wt) HA-CB 2 cDNA (2 g per plate) or mutant cDNAs (4 g per plate) and, where indicated, with AC-V cDNA (1.5 g per plate). pXMD1-gal cDNA was used for mock DNA transfection. For binding studies, 72 h after transfection, the COS cells were washed twice with phosphate-buffered saline, scraped off, and centrifuged at 3,000 rpm for 10 min, and the cell pellets were stored at Ϫ70°C. For AC assay, 48 h after transfection, the COS cells were trypsinized and recultured in 24-well plates, and after an additional 24 h, the cells were assayed for AC activity as described below. Transfection efficiency was normally in the range of 40 -80%, as determined by staining the cells for the activity of transfected ␤-galactosidase (Avidor- Reiss et al., 1996) .
FIG. 1.
Location of W158 and W172 in the CB 2 receptor and the alignment of the amino acid sequence of various GPCRs around these areas. A: General structure of the CB 2 receptor. B: Amino acid sequences around positions 4.50 and 4.64 of several GPCRs, as obtained from Attwood et al. (1991) , Probst et al. (1992) , and Horn et al. (1998) .
AC activity
The assay was performed in triplicate as described previously Rhee et al., 1998) . In brief, cells cultured in 24-well plates were incubated for 2 h with 0.25 ml/well fresh growth medium containing 5 Ci/ml [2-
3 H]adenine. This medium was replaced with Dulbecco's modified Eagle's medium containing 20 mM HEPES (pH 7.4) and the phosphodiesterase inhibitors Ro 20-1724 (0.5 mM) and 3-isobutyl-1-methylxanthine (0.5 mM). Cannabinoids diluted in 10 mg/ml fatty acid-free bovine serum albumin were then added. AC activity was stimulated in the presence or absence of cannabinoids by addition of 2 M forskolin. After 10 min at 37°C, the medium was removed, and the reaction was terminated by adding to the cell layer 1 ml of 2.5% perchloric acid containing 0.1 mM unlabeled cAMP. Aliquots of 0.9 ml of the acidic extract were neutralized with 100 l of 3.8 M KOH and 0.16 M K 2 CO 3 and applied to a two-step column separation procedure (Salomon, 1991 
Binding of [ 3 H]HU-243
This assay was performed as described previously Rhee et al., 1997) . Frozen pellets of transfected cells were homogenized in 2 ml of binding buffer per plate, and 100-l aliquots of crude cell homogenates containing 15-20 g protein [as determined by the method of Bradford (1976) ] were mixed with 300 fmol of the high-affinity cannabinoid agonist [
3 H]HU-243 in 1.5-ml Eppendorf tubes in a final volume of 1 ml of 50 mM Tris-HCl, 5 mM MgCl 2 , 10 mM CaCl 2 , 2.5 mM EDTA (pH 7.4), and 2 mg/ml fatty acid-free bovine serum albumin. The binding mixtures were incubated at 30°C for 1.5 h with gentle shaking and centrifuged at 14,000 rpm for 10 min. The bottoms of the 1.5-ml tubes were then cut and counted for radioactivity. Nonspecific binding determined in the presence of 1 M HU-210 was subtracted from all values. The K i values for the cannabinoid agonists HU-210, WIN55,212-2, and CP55,940 were determined by adding increasing concentrations of these materials to the binding mixtures together with [ 3 H]HU-243 and applying the formula Rhee et al., 1997) .
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and western immunoblotting
COS-7 cells transfected with the various HA-tagged CB 2 cDNAs in 10-cm-diameter culture plates were harvested with cold phosphate-buffered saline and spun down at 3,000 rpm (at 4°C for 10 min), and the cell pellets were mixed with 100 l of Laemmli sample buffer per plate, sonicated, and frozen at Ϫ20°C. Samples of 10 l (containing 30 g of protein) were incubated for 5 min at 100°C with dithiothreitol (final concentration, 0.1 M) before loading onto 1.5-mm-thick 10% polyacrylamide gel. Following gel electrophoresis, proteins were blotted onto nitrocellulose membrane, and the blot was blocked in phosphate-buffered saline containing 5% fat-free milk and 0.5% Tween-20, followed by a 1.5-h incubation with anti-HA monoclonal antibody (HA.11; Boehringer Mannheim) diluted 1:1,000 in 5% fat-free milk and 0.5% Tween-20. Blots were washed three times with phosphate-buffered saline containing 0.3% Tween-20 and incubated for 1 h with horseradish peroxidase-coupled rat anti-mouse antibodies (Jackson Immunoresearch Laboratories) diluted 1:20,000 in 5% fat-free milk plus 0.5% Tween-20. The blot was extensively washed, and peroxidase activity was observed by the enhanced chemiluminescence (ECL) technique (Amersham).
Data analysis
Data are mean Ϯ SEM values. Dose-response curves were plotted using the Sigma Plot version 4.11 program.
RESULTS
To study the role of W158 and W172 residues in binding and signaling of the CB 2 receptor, we replaced W158 with either Y or F (thus conserving the aromatic side chain, with or without a hydroxyl group) or with L (thus completely removing the aromatic side chain). A similar study was performed with W172, which was replaced with either F or Y or with A or L.
Role of W158 in CB 2 binding and signaling Figure 2A demonstrates by western blot analysis (using antibodies against the HA tag) that all the W158 mutants were efficiently expressed, although, in general, the wt receptor was more highly expressed than the mutated forms (by up to threefold). Two immunoreactive bands could be observed. The molecular size of the lower immunoreactive band is 41 kDa, which is consistent with the amino acid composition of the HA-tagged receptor and with the molecular mass obtained for the expressed human CB 2 receptor protein (Nowell et al., 1998) . The somewhat higher molecular mass of the second immunoreactive band (Ϸ43 kDa) could represent a glycosylated form of the receptor. However, we cannot rule out the presence of small amounts of more highly glycosylated forms of the receptor.
Using homologous competition binding of HU-243 to determine the binding properties and possible changes in B max and K D of the mutants, we found (Fig. 2B ) that W158A did not bind [ 3 H]HU-243. It is interesting that the replacement of this W residue with Y also led to a complete loss of binding activity. On the other hand, the conservative substitution of W158F retained most of its binding capacity. A small reduction in the B max of the binding of HU-243 and a very small reduction in binding affinity were observed for W158Y versus the wt receptor.
We then analyzed the capacity of HA-CB 2 (wt) and the W158 mutants to inhibit AC activity. The COS cells were cotransfected with rabbit AC-V together with either HA-CB 2 (wt) or the mutated receptors, and the effect of increasing concentrations of HU-210 or WIN55,212-2 on forskolin-stimulated AC activity was determined. The results ( Fig. 2C and D) show that, in agreement with the results of the binding studies, W158A and W158L showed only a very slight inhibition of AC activity in response to relatively high (1 M) concentrations of HU-210 or WIN55,212-2. On the other hand, the W158F mutant showed an identical AC inhibition pattern to that obtained with HA-CB 2 (wt). The EC 50 values calculated for the inhibition of AC by W158F and HA-CB 2 (wt) were 1.2 Ϯ 0.2 versus 1.0 Ϯ 0.3 nM for HU-210 and 2.7 Ϯ 0.8 versus 1.9 Ϯ 0.9 nM for WIN55,212-2. In simi-ROLE OF TRP IN CB2 SIGNALING larity with these results, obtained with exogenous cannabinoids, the application of 2-arachidonoylglycerol (in the presence of phenylmethylsulfonyl fluoride to protect it from degradation) led to similar AC inhibition following activation of either W158F or the wt receptor, with EC 50 values of 350 Ϯ 160 and 230 Ϯ 80 nM, respectively, and it had no effect on the W158A mutant (data not shown).
Role of W172 in CB 2 binding and signaling
Subsequently, the role of W172 in CB 2 binding and signaling was investigated. Figure 3A shows that all the W172 mutants examined were efficiently expressed, reaching levels similar to that of HA-CB 2 (wt). Figure  3B shows and 140 Ϯ 20 pM versus 160 Ϯ 70 pM for the wt receptor. Similarly, the binding of the bicyclic cannabinoid CP55,940 was not affected by these mutations, showing binding affinities of 6.4 Ϯ 1.7 and 6.9 Ϯ 0.9 nM versus 5.9 Ϯ 1.0 nM for the wt receptor. On the other hand, the binding of the aminoalkylindole WIN55,212-2 was slightly reduced by the mutations, demonstrating a K i of 3.6 Ϯ 0.5 and 3.6 Ϯ 1.2 nM for W172F and W172Y mutants versus 1.0 Ϯ 0.3 nM for the wt receptor.
The analysis of the capacity of the W172 mutants to inhibit AC activity is shown in Fig. 4B and C. We found that, in complete agreement with the binding studies, agonist activation of W172L did not inhibit and that of W172A only negligibly inhibited AC activity. On the other hand, using HU-210, WIN55,212-2, or 2-arachidonoylglycerol, we found that the W172F and W172Y mutants showed similar AC inhibition patterns to that observed with the wt receptor. The EC 50 values calculated for the inhibition of AC by W172F, W172Y, and HA-CB 2 (wt) were 1.4 Ϯ 0.3, 1.3 Ϯ 0.6, and 2.0 Ϯ 0.6 nM for HU-210 and 2.0 Ϯ 0.3, 1.3 Ϯ 0.2, and 1.7 Ϯ 0.3 nM for WIN55,212-2, respectively.
DISCUSSION
All exogenous cannabinoid ligands (classical tricyclic cannabinoids, bicyclic cannabinoids, and aminoalkylindoles) have an aromatic ring and/or a long hydrophobic side chain, which were shown to have an important role in receptor binding and signaling (Howlett, 1995) . For example, it was suggested that the aminoalkylindole WIN55,212-2 interacts with both CB 1 and CB 2 by aromatic stacking (Reggio et al., 1998) . The replacement of the pentyl group with a dimethylheptyl group at position 3 of the cyclic and bicyclic cannabinoids was found to increase ligand affinity to CB 1 and CB 2 . It was therefore inferred that a hydrophobic region in both receptors accommodates this hydrophobic side chain (Rhee et al., 1997; Howlett, 1998) .
Using a chimeric construct of the CB 1 and CB 2 receptors and site-directed mutagenesis, Shire et al. (1999) have shown that the region consisting of TM4 -extracellular loop 2-TM5 of both CB 1 and CB 2 contains residues that are critical for binding of cannabinoid agonists and antagonists. The aromatic side chain of the Trp residue is known to be involved in aromatic-aromatic interactions, cation-interactions, and amino group-aromatic interactions (Waksman et al., 1992; Dougherty, 1996) . W172, located at the top of TM4, and the conserved W158, just below the middle of TM4, are thus good candidates for having a role in cannabinoid ligand-receptor interactions.
Various aromatic amino acids in the fourth and other TM domains have been studied for ligand binding and signaling in a large variety of GPCRs, including the m 1 and m 3 muscarinic, 5-HT 2 serotonergic, NK 2 tachykinin, and ␦-opioid receptors (Wess et al., 1992 (Wess et al., , 1993 Choudhary et al., 1993; Matsui et al., 1995; Befort et al., 1996; Roth et al., 1997; Renzetti et al., 1999a,b) . In similarity to the data presented here, Befort et al. (1996) found that W173 of the ␦-opioid receptor (in an analogous position to W158 of CB 2 ) is involved in receptor- ligand recognition and that mutation of this amino acid reduced the receptor's binding affinity to many ␦ ligands. Similar results were obtained with the cognate W163A mutation of the human Y 1 receptor (Sautel et al., 1996) and with the W200A mutation of the 5-HT 2A receptor. It is interesting that Wess et al. (1993) reported that mutating W192 of the m 3 muscarinic receptor to F only slightly reduced agonist binding affinity and signaling. In line with this result, we show here that although W158 in CB 2 is very important for receptor activity, the conservative W158F mutation has little or no effect on cannabinoid binding and signaling. This result suggests that the hydrophobic interaction of W158 either with the ligand or with an appropriate area of the receptor is critical for receptor function and is conserved in W158F but not when this residue is altered into an aliphatic amino acid or even into Tyr. The fact that Tyr at this site interferes with receptor function could be due to interference by the OH group or by the change in electron distribution compared with that present in Trp or Phe.
Both the W172A and W172L mutants were well expressed. However, W172A showed almost no apparent binding and relatively low inhibition of AC, and W172L did not bind HU-243 and did not show any AC inhibition. This result is in line with the finding that the W164A mutation in the m 1 muscarinic receptor significantly affected agonist binding (Matsui et al., 1995) . Taken together, these results suggest that the Trp residue at this position is involved in ligand binding. However, we cannot exclude the possibility that this amino acid, rather than directly interacting with the cannabinoid ligand, could also affect the conformation of the binding pocket. Some of the reduction in the apparent binding of [ 3 H]HU-243 to either the W158Y and W158A, or the W172L and W172A mutants, could be explained by a reduction in receptor-G protein coupling as it is known that agonists bind with lesser affinity to G protein-uncoupled receptors. These experiments should therefore be verified as soon as a labeled CB 2 antagonist becomes available. However, the fact that, as described above, cognate mutations in other receptors showed a reduction in receptor-ligand recognition suggests that the observed reduction in binding described above is due to an actual reduction in binding.
It is of interest to note that although both W158 and W172 of the CB 2 receptor seem to have an important role in receptor-ligand interaction, W172 shows a less stringent structural requirement as this residue could be replaced with either F or Y, whereas W158 could only be replaced with F. This result is in agreement with the complete conservation of the W residue at position 4.50 of almost all GPCRs, whereas the W at position 4.64 is not generally conserved.
